Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of UK-390,957 in Men With Premature Ejaculation
NCT00219583Phase 3Completed
- Sponsor
- Pfizer
- Start
- Aug 2004
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of UK-390957 in premature ejaculation (PE), sponsored by Pfizer. Started Aug 2004; status: completed.
02
Drugs
UK-390957
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on NCT00219583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00219583.